The effect of age of onset of PD on risk of dementia

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].

Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589

Older Adults' Reasons for Using Technology while Aging in Place

Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378

Overdependence on degraded gist memory in Alzheimer's disease.

Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,757

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,346

The clinical symptoms of Parkinson's disease.

Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 928

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

Irwin, D. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3549 · Cited by 914

MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI

Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevsky, J., Mollenhauer, B., Rodríguez‐Oroz, M., Tröster, A. I., & Weintraub, D. A. (2011) · Movement Disorders · doi:10.1002/mds.23823 · Cited by 811

Lewy body dementias

Walker, Z., Possin, K. L., Boeve, B. F., & Aarsland, D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00462-6 · Cited by 632

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Compta, Y., Parkkinen, L., O’Sullivan, S. S., Vandrovcová, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 607

The epidemiology of dementia associated with Parkinson disease

Aarsland, D., & Kurz, M. W. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.034 · Cited by 572

Neuropathologic substrates of Parkinson disease dementia

Irwin, D. J., White, M. T., Toledo, J. B., Xie, S. X., Robinson, J. L., Van Deerlin, V., Lee, V. M. ‐., Leverenz, J. B., Montine, T. J., Duda, J. E., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23659 · Cited by 518

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

Svenningsson, P., Westman, E., Ballard, C. G., & Aarsland, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70152-7 · Cited by 517

Dementia and survival in Parkinson disease: A 12-year population study

Buter, T. C., van den Hout, A., Matthews, F. E., Larsen, J. P., Brayne, C., & Aarsland, D. (2008) · Neurology · doi:10.1212/01.wnl.0000306632.43729.24 · Cited by 451

Ageing, neurodegeneration and Parkinson's disease

Hindle, J. V. (2010) · Age and Ageing · doi:10.1093/ageing/afp223 · Cited by 430

Epidemiology of Parkinson’s disease

Alves, G. W., Forsaa, E. B., Pedersen, K. F., Gjerstad, M. D., & Larsen, J. P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5004-3 · Cited by 405

Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

Kang, J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3861 · Cited by 366

The Epidemiology of Dementia Associated with Parkinson's Disease

Aarsland, D., & Kurz, M. W. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00369.x · Cited by 357

Prognosis of Mild Cognitive Impairment in Early Parkinson Disease: The Norwegian ParkWest Study

Pedersen, K. F., Larsen, J. P., Tysnes, O.-B., & Alves, G. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2110 · Cited by 315

Progression of Parkinson's disease in the clinical phase: potential markers

Maetzler, W., Liepelt, I., & Berg, D. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70291-1 · Cited by 307

Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia

Elamin, M., Phukan, J., Bede, P., Jordan, N., Byrne, S., Pender, N. P., & Hardiman, O. M. (2011) · Neurology · doi:10.1212/wnl.0b013e318214359f · Cited by 301

The progression of pathology in Parkinson's disease

Halliday, G. M., & McCann, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05118.x · Cited by 298

Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis

Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations

Škorvánek, M., Goldman, J. G., Jahanshahi, M., Marras, C., Rektorová, I., Schmand, B. A., van Duijn, E., Goetz, C. G., Weintraub, D. A., Stebbins, G. T., et al. (2017) · Movement Disorders · doi:10.1002/mds.27233 · Cited by 231

Clinical subtypes of Parkinson's disease

van Rooden, S. M., Colas, F., Martínez‐Martín, P., Jeukens‐Visser, M., Verbaan, D., Marinus, J., Chaudhuri, К. R., Kok, J. N., & van Hilten, J. J. (2010) · Movement Disorders · doi:10.1002/mds.23346 · Cited by 228

Mild Cognitive Impairment in Parkinson’s Disease

Aarsland, D., Brønnick, K., & Fladby, T. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0203-1 · Cited by 213

Visual symptoms in Parkinson's disease and Parkinson's disease dementia

Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23891 · Cited by 220

Milestones in Parkinson's disease—Clinical and pathologic features

Halliday, G. M., Lees, A. J., & Stern, M. (2011) · Movement Disorders · doi:10.1002/mds.23669 · Cited by 218

Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease

Compta, Y., Martı́, M. J., Ibarretxe‐Bilbao, N., Junqué, C., Valldeoriola, F., Muñoz, E., Ezquerra, M., Ríos, J., & TOLOSA, E. S. (2009) · Movement Disorders · doi:10.1002/mds.22594 · Cited by 185

Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management

Meireles, J., & Massano, J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00088 · Cited by 181

Epidemiology of neurological diseases in older adults

Dumurgier, J., & Tzourio, C. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.01.356 · Cited by 183

Cognitive impairment in early-stage non-demented Parkinson's disease patients

Pfeiffer, H. C. V., Løkkegaard, A., Zoetmulder, M., Friberg, L., & Werdelin, L. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12189 · Cited by 162

Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study

Santangelo, G., Vitale, C., Picillo, M., Moccia, M., Cuoco, S., Longo, K., Pezzella, D., di Grazia, A., Erro, R., Pellecchia, M. T., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.08.024 · Cited by 149

Amyloid PET Imaging in Lewy Body Disorders

Donaghy, P. C., Thomas, A. J., & O'Brien, J. T. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.03.001 · Cited by 118

The Therapeutic Role of Ketogenic Diet in Neurological Disorders

Pietrzak, D., Kasperek, K., Rękawek, P., & Piątkowska‐Chmiel, I. (2022) · Nutrients · doi:10.3390/nu14091952 · Cited by 136

Sequence of clinical and neurodegeneration events in Parkinson’s disease progression

Oxtoby, N. P., Leyland, L., Aksman, L., Thomas, G. E. C., Bunting, E. L., Wijeratne, P. A., Young, A. L., Zarkali, A., Tan, M. M. X., Bremner, F., et al. (2021) · Brain · doi:10.1093/brain/awaa461 · Cited by 102

Virtual multiple errands test (VMET): a virtual reality-based tool to detect early executive functions deficit in Parkinson’s disease

Cipresso, P., Albani, G., Serino, S., Pedroli, E., Pallavicini, F., Mauro, A., & Riva, G. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00405 · Cited by 103

Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future

Lang, A. E. (2010) · Nature Medicine · doi:10.1038/nm.2220 · Cited by 95

Dementia in Parkinson's disease

Aarsland, D., Beyer, M. K., & Kurz, M. W. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283168df0 · Cited by 95

Biomarkers of cognitive decline in Parkinson's disease

Lin, C., & Wu, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.010 · Cited by 100

Dementia in Parkinson's disease: Is male gender a risk factor?

Cereda, E., Cilia, R., Klersy, C., Siri, C., Pozzi, B., Reali, E., Colombo, A., Zecchinelli, A., Mariani, C. B., Tesei, S., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.024 · Cited by 83

Cognitive impairment in Parkinson's disease

Cosgrove, J., Alty, J., & Jamieson, S. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133247 · Cited by 78

Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease

Alcalay, R. N., Mejia‐Santana, H., Mirelman, A., Saunders-Pullman, R. J., Raymond, D., Palmese, C. A., Caccappolo, E., Ozelius, L. J., Orr‐Urtreger, A., Clark, L. N., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.09.033 · Cited by 76

Arguing against the proposed definition changes of PD

Boeve, B. F., Dickson, D. W., Duda, J. E., Ferman, T. J., Galasko, D. R., Galvin, J. E., Goldman, J. G., Growdon, J. H., Hurtig, H. I., Kaufer, D., et al. (2016) · Movement Disorders · doi:10.1002/mds.26721 · Cited by 76

Meta-analysis of risk factors for Parkinson’s disease dementia

Xu, Y., Yang, J., & Shang, H. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0058-0 · Cited by 70

Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia

Zoccolella, S., Dell’Aquila, C., Abruzzese, G., Antonini, A., Bonuccelli, U., Canesi, M., Cristina, S., Marchese, R., Pacchetti, C., Zagaglia, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22511 · Cited by 65

Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease

Biundo, R., Weis, L., Pilleri, M., Facchini, S., Formento‐Dojot, P., Vallelunga, A., & Antonini, A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1004-2 · Cited by 61

Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease

Ezquerra, M., Campdelacreu, J., Gaig, C., Compta, Y., Muñoz, E., Martı́, M. J., Valldeoriola, F., & TOLOSA, E. S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.018 · Cited by 60

Mind the gaps: What we don't know about cognitive impairment in essential tremor

Louis, E. D., Joyce, J. L., & Cosentino, S. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.038 · Cited by 58

Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment

Chung, S. J., Yoo, H. S., Lee, Y. H., Lee, H. S., Ye, B. S., Sohn, Y. H., Kwon, H., & Lee, P. H. (2019) · Human Brain Mapping · doi:10.1002/hbm.24631 · Cited by 56

Risk of Dementia in Parkinson's Disease: A Systematic Review and Meta‐Analysis

Gibson, L. L., Weintraub, D. A., Lemmen, R., Perera, G., Chaudhuri, К. R., Svenningsson, P., & Aarsland, D. (2024) · Movement Disorders · doi:10.1002/mds.29918 · Cited by 55

Nonlinear decline of mini‐mental state examination in Parkinson's disease

Aarsland, D., Terrera, G. M., & Matthews, F. E. (2010) · Movement Disorders · doi:10.1002/mds.23416 · Cited by 50

Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment

Zhou, C., Guan, X., Guo, T., Zeng, Q., Gao, T., Huang, P., Xuan, M., Gu, Q., Xu, X., & Zhang, M. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13188 · Cited by 45

Is all cognitive impairment in Parkinson’s disease “mild cognitive impairment”?

Martínez‐Horta, S., & Kulisevsky, J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0675-9 · Cited by 43

The long-term development of non-motor problems after STN-DBS

Lilleeng, B., Gjerstad, M. D., Baardsen, R., Dalen, I., & Larsen, J. O. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12391 · Cited by 42

Cognitive impairment and dementia in Parkinson's disease

Marder, K. S. (2010) · Movement Disorders · doi:10.1002/mds.22787 · Cited by 43

Longitudinal Assessment of the Pattern of Cognitive Decline in Non-Demented Patients with Advanced Parkinson's Disease

Gasca‐Salas, C., Estanga, A., Clavero, P., Aguilar‐Palacio, I., Gonzalez-Redondo, R., Obeso, J. A., & Rodríguez-Oroz, M. C. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-140398 · Cited by 49

Cardiovascular risk factors and the risk of Parkinson’s disease

Vikdahl, M., Bäckman, L., Johansson, I., Forsgren, L., & Håglin, L. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.259 · Cited by 40

The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease

Ciccarelli, N., Monaco, M. R. L., Fusco, D., Vetrano, D. L., Zuccalà, G., Bernabei, R., Brandi, V., Pisciotta, M. S., & Silveri, M. C. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0838-0 · Cited by 40

Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias

Fields, J. A. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx085 · Cited by 40

A Composite Fabric-Based Soft Rehabilitation Glove With Soft Joint for Dementia in Parkinson’s Disease

Chen, Y., Tan, X., Yan, D., Zhang, Z., & Gong, Y. (2020) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2020.2981926 · Cited by 39

Mild Cognitive Impairment in Parkinson’s Disease: A Review of Current Concepts

Palavra, N. C., Naismith, S. L., & Lewis, S. J. G. (2013) · Neurology Research International · doi:10.1155/2013/576091 · Cited by 39

Caregiver Burden in Parkinson Disease with Dementia Compared to Alzheimer Disease in Korea

Shin, H., Youn, J., Kim, J. S., Lee, J.-Y., & Cho, J. W. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712464819 · Cited by 38

Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease

Tang, H., Huang, J., Nie, K., Gan, R., Wang, L., Zhao, J., Huang, Z., Zhang, Y., & Wang, L. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1010646 · Cited by 37

Temporal trajectory of biofluid markers in Parkinson’s disease

Baek, M. S., Lee, M. J., Kim, H., & Lyoo, C. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-94345-8 · Cited by 35

Frontal lobe metabolic alterations characterizing Parkinson’s disease cognitive impairment

Chaudhary, S., Kumaran, S. S., Goyal, V., Kalaivani, M., Kaloiya, G. S., Sagar, R., Mehta, N., Srivastava, A. K., & Jagannathan, N. R. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04626-9 · Cited by 32

Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting

Almuqbel, M. M., Melzer, T. R., Myall, D. J., MacAskill, M. R., Pitcher, T. L., Livingston, L., Horne, K., Keenan, R. J., Dalrymple‐Alford, J. C., & Anderson, T. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.11.008 · Cited by 32

Apomorphine therapy in Parkinson's disease and future directions

Titova, N., & Chaudhuri, К. R. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.11.013 · Cited by 31

Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease

Scheffels, J. F., Fröhlich, L., Kalbe, E., & Kessler, J. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116735 · Cited by 30

Cognitive dysfunction in Nigerians with Parkinson's disease

Akinyemi, R., Okubadejo, N. U., Akinyemi, J. O., Owolabi, M. O., Owolabi, L. F., & Ogunniyi, A. O. (2008) · Movement Disorders · doi:10.1002/mds.22087 · Cited by 30

Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson’s Disease

Lichter, D. G., Benedict, R. H. B., & Hershey, L. A. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181375 · Cited by 28

Cognitive Training in Parkinson’s Disease: A Review of Studies from 2000 to 2014

Glizer, D., & MacDonald, P. A. (2016) · Parkinson s Disease · doi:10.1155/2016/9291713 · Cited by 30

Predictors of Parkinson's disease dementia: Towards targeted therapies for a heterogeneous disease

Moore, S. F., & Barker, R. A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70026-9 · Cited by 25

Effects of Improvisational Dance Movement Therapy on Balance and Cognition in Parkinson’s Disease

Fisher, M., Kuhlmann, N., Moulin, H., Sack, J., Lazuk, T., & Gold, I. (2020) · Physical & Occupational Therapy In Geriatrics · doi:10.1080/02703181.2020.1765943 · Cited by 25

LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson’s disease and dementia with Lewy bodies

Grochowska, M. M., Mascaro, A. C., Boumeester, V., Natale, D., Breedveld, G. J., Geut, H., van Cappellen, W. A., Boon, A. J. W., Kievit, A. J. A., Sammler, E. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02313-3 · Cited by 22

Air pollution: a latent key driving force of dementia

Mohammadzadeh, M., Khoshakhlagh, A. H., & Grafman, J. H. (2024) · BMC Public Health · doi:10.1186/s12889-024-19918-4 · Cited by 26

Development of Clinical Dementia Rating Scale Cut‐off Scores for Patients With Parkinson's Disease

Wyman‐Chick, K. A., & Scott, B. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12163 · Cited by 24

SLC6A4 Repeat and Single-Nucleotide Polymorphisms Are Associated With Depression and Rest Tremor in Parkinson's Disease: An Exploratory Study

Wang, J., Fan, Q.-Y., He, J., Zhu, S.-G., Huang, C.-P., Zhang, X., & Zhu, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00333 · Cited by 22

Cortico-Subcortical Dynamics in Parkinson¿s Disease

Cuomo, D., Platania, P., SCIAMANNA, G., Tassone, A., MARTELLA, G., MADEO, G., & PISANI, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0 · Cited by 21

Grey matter atrophy in early versus late dementia in Parkinson's disease

Beyer, M. K., & Aarsland, D. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.01.021 · Cited by 19

A global view of Parkinson's disease pathogenesis: Implications for natural history and neuroprotection

Linazasoro, G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.011 · Cited by 19

Nonmotor symptoms in Parkinson‘s disease: the dark side of the moon

Ceravolo, R., Rossi, C. A., Kiferle, L., & Bonuccelli, U. (2010) · Future Neurology · doi:10.2217/fnl.10.69 · Cited by 15

Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson’s Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis

Liebermann‐Jordanidis, H., Roheger, M., Boosfeld, L., Franklin, J. G., & Kalbe, E. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223238 · Cited by 14

Acceptance of Cognitive Games through Smart TV Applications in Patients with Parkinson's Disease

López, J. P., Martín, D., Moreno, F., Hernández-Peñaloza, G., Álvarez, F., Marín, M., Carrasco, L., & Burgos, M. (2018) · International Conference on PErvasive Technologies Related to Assistive Environments (PETRA) · doi:10.1145/3197768.3201553 · Cited by 13

A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease

Huang, M., Yu, H., Cai, X., Zhang, Y., Pu, W., & Gao, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-41569-5 · Cited by 13

Inventory of real world data sources in Parkinson’s disease

Melac, A. T., Jönsson, L., & Ishihara, L. (2017) · BMC Neurology · doi:10.1186/s12883-017-0985-0 · Cited by 13

Cognitive Profiles in Parkinson’s Disease and Their Relation to Dementia: A Data-Driven Approach

Liepelt‐Scarfone, I., Gräber, S., Berger, M. F., Feseker, A., Baysal, G. Ö. D., Csóti, I., Godau, J., Gaenslen, A., Huber, H., Srulijes, K., et al. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/910757 · Cited by 12

Data analysis from cognitive games interaction in Smart TV applications for patients with Parkinson's, Alzheimer's, and other types of dementia

López, J. P., Moreno, F., Popa, M. C., Hernández-Peñaloza, G., & Álvarez, F. (2019) · Artificial intelligence for engineering design analysis and manufacturing · doi:10.1017/s0890060419000386 · Cited by 13

Total Burden of Cerebral Small Vessel Disease on MRI May Predict Cognitive Impairment in Parkinson’s Disease

Zhu, R., Li, Y., Chen, L., Wang, Y.-Q., Cai, G., Chen, X., Ye, Q., & Chen, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185381 · Cited by 10

Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson’s Disease

Liu, J.-Y., Ma, L., Wang, J., Cui, X.-J., Sheng, Z.-H., Fu, Y., Li, M., Ou, Y., Yu, J., Tan, L., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220976 · Cited by 11

Clinical Profile of Cognitive Decline in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy

Gupta, D., Sharma, A. K., Kumar, N., & Sulena (2017) · Journal of Neurosciences in Rural Practice · doi:10.4103/jnrp.jnrp_154_17 · Cited by 10

Cognitive Function Characteristics of Parkinson’s Disease with Sleep Disorders

Huang, J., Zhuo, W., Zhang, Y., Sun, H., Chen, H., Zhu, P., Pan, X.-B., Yang, J. M., & Wang, L. (2017) · Parkinson s Disease · doi:10.1155/2017/4267353 · Cited by 10

Risk factors and predictors for Lewy body dementia: a systematic review

Ratnavel, A., Dino, F., Jiang, C., Azmy, S., Wyman‐Chick, K. A., & Bayram, E. (2025) · npj Dementia · doi:10.1038/s44400-025-00022-2 · Cited by 9

The Impact of Sex‐Specific Survival on the Incidence of Dementia in Parkinson's Disease

Fink, A., Dodel, R. C., Georges, D., & Doblhammer, G. (2023) · Movement Disorders · doi:10.1002/mds.29596 · Cited by 8

Stereotypies after herpetic encephalitis with bitemporal lesions

Twardowschy, C. A., de Paola, L., Teive, H. A. G., & Silvado, C. E. (2010) · Movement Disorders · doi:10.1002/mds.22803 · Cited by 8

Clinical Features and Differential Diagnosis of Parkinson’s Disease

Magdalinou, N. K., & Morris, H. R. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1628-9_11 · Cited by 8

Cognitive Deficits in Parkinson’s Disease

Gerschcovich, E. R., & Tseng, K. Y. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_19 · Cited by 8

Deciphering Parkinson’s Disease through Eye Movements: A Promising Tool for Early Diagnosis in the Face of Cognitive Impairment

Liao, X., Yao, J., Tang, H., Xing, Y., Zhao, X., Nie, D., Luan, P., & Li, G. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/5579238 · Cited by 7

Cognitive deficits in Parkinson’s disease: current perspectives

Cosgrove, J., & Alty, J. (2018) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s125064 · Cited by 10

Cognitive and Psychiatric Disturbances in Parkinson’s Disease

Aarsland, D., Ehrt, U., & Rektorová, I. (2011) · Aging Health · doi:10.2217/ahe.11.3 · Cited by 6

Statistical Models of Parkinson’s Disease Progression: Predictive Validity in a 3-Year Follow-up

Mendes, A., Gonçalves, A., Vila‐Chã, N., Calejo, M., Moreira, I. C., Fernandes, J., Damásio, J., Teixeira-Pinto, A. M., Krack, P., Lima, A. B., et al. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160877 · Cited by 6

Dementia-Free Survival and Risk Factors for Dementia in a Hospital-Based Korean Parkinson's Disease Cohort

Lee, S. Y., Ryu, H.-J., Seo, J.-W., Noh, M. S., Cheon, S., & Kim, J. W. (2017) · Journal of Clinical Neurology · doi:10.3988/jcn.2017.13.1.21 · Cited by 6

A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease

Hughes, T. A., Ross, H., Musa, S., Bhattacherjee, S., Nathan, R. N., Mindham, R. H. S., & SPOKES, E. G. S. (2000) · Neurology · doi:10.1212/wnl.54.8.1596 · Cited by 368

How does the age of onset of Parkinson's disease correlate with the likelihood or age of developing dementia?

Tripdatabase (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.18778468

Risk of dementia in Parkinson’s disease: A community-based, prospective study

Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721

Age-Stratified Risk of Dementia in Parkinson's Disease: A Nationwide, Population-Based, Retrospective Cohort Study in Taiwan

Chang, T.-Y., Yang, C., Chen, Y.-H., Lin, C., & Chang, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.748096 · Cited by 13

Risk of dementia after Parkinson’s disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims

Liu, C., Sun, Y., Lee, P., Li, C., & Hu, S. C. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025274 · Cited by 15